Avecia

Avecia is a leading contract process development and manufacturer of microbial-derived biologics and oligonucleotides.  Avecia Biologics, based in the north east of the UK, has one of Europe’s largest cGMP contract manufacturing facilities for recombinant protein biologics, offering flexible capacity from 100L - 5000L for all stages of the product pipeline.  Avecia OligoMedicines, based in Milford, MA, is the world leader in the development and cGMP manufacture of oligonucleotides at all clinical phases.

.
Is this your Organization?   Request Access

Locations


United Kingdom
Avecia Biologics
Tees Valley,
United Kingdom, Europe

GMP Experience
FDA and MHRA inspected. These facilities have successfully manufactured over 50 protein therapeutics for use in human clinical trials.
United States
Avecia OligoMedicines
Milford, MA
United States, North America

GMP Experience
Avecia OligoMedicines is the longest established oligonucleotide Contract Manufacturing Organization (CMO). We pride ourselves on being flexible, responsive, and customer intimate.

Contacts


Send Email to Bridget Hall
Bridget Hall
Communications Manager

Production Lines

Avecia Biologics    ABC 1000
Location: Tees Valley, United Kingdom
Main Details
Specialization:  Drug Substance (API)Drug Substance (API)
Platform:  MicrobialMicrobial
BioReactor Process:  BatchBatch
BioReactor Process:  Fed-BatchFed-Batch
BioReactor Scale:  100L-2000L1000L Bioreactor
GMP Level:  Phase IIIPhase III
Biosafety Level:  Biosafety Level 2Biosafety Level 2
Additional Services
Analytical Services are AvailableAnalytical Services
Cell Banking is AvailableCell Banking
Cell Line Development is Not AvailableCell Line Development
Preclinical Manufacturing is AvailablePreclinical Manufacturing
Process Development is AvailableProcess Development
Viral Manufacturing is Not AvailableViral Manufacturing
Availability: Available

Last Update: 23OCT09

Send Inquiry about this Production Line
Avecia Biologics    ABC5000
Location: Tees Valley, United Kingdom
Main Details
Specialization:  Drug Substance (API)Drug Substance (API)
Platform:  MicrobialMicrobial
BioReactor Process:  BatchBatch
BioReactor Scale:  2000L-5000L5000L Bioreactor
GMP Level:  CommercialCommercial
Biosafety Level:  Not SpecifiedNot Specified
Additional Services
Analytical Services are AvailableAnalytical Services
Cell Banking is AvailableCell Banking
Cell Line Development is Not AvailableCell Line Development
Preclinical Manufacturing is AvailablePreclinical Manufacturing
Process Development is AvailableProcess Development
Viral Manufacturing is Not AvailableViral Manufacturing
Availability: Contact CMO

Last Update: 23OCT09

Send Inquiry about this Production Line

Copyright © Kymanox, All Rights Reserved.